Droloxifene citrate manufacturers
- Droloxifene citrate
-
- $0.10 / 1KG
-
2019-12-26
- CAS:97752-20-0
- Min. Order: 1KG
- Purity: 95%-99%
- Supply Ability: 1kg; 50kg
|
| | Droloxifene citrate Basic information |
| Product Name: | Droloxifene citrate | | Synonyms: | (E)-[2-[4-[1-(3-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate;(E)-1-(4'-(2-Dimethylaminoethoxy)phenyl)-1-(3-hydroxyphenyl)-2-phenylbut-1-ene citrate;Droloxifene citrate;GTJXPMSTODOYNP-BTKVJIOYSA-N;(E)-[2-[4-[1-(3-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate | | CAS: | 97752-20-0 | | MF: | C58H66N2O11 | | MW: | 967.15144 | | EINECS: | 307-782-5 | | Product Categories: | | | Mol File: | 97752-20-0.mol |  |
| | Droloxifene citrate Chemical Properties |
| Melting point | >143°C (dec.) | | storage temp. | Amber Vial, -20°C Freezer | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | color | White to Off-White | | Stability: | Light Sensitive | | CAS DataBase Reference | 97752-20-0(CAS DataBase Reference) |
| | Droloxifene citrate Usage And Synthesis |
| Uses | Antineoplastic. | | Uses | Droloxifene is a non-steroidal anti-oestrogen that is structurally related to Tamoxifen (T006000), a drug used to prevent the occurrence of breast cancer in postmenopausal women. Droloxifene has a very high binding affinity to estrogen receptors and is used, similarly to Tamoxifen, to prevent and treat breast cancer. |
| | Droloxifene citrate Preparation Products And Raw materials |
|